Suppr超能文献

胃癌管用于癌症患者的营养和恶性肠梗阻。

Gastrostomy Tube for Nutrition and Malignant Bowel Obstruction in Patients With Cancer.

机构信息

1Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.

出版信息

J Natl Compr Canc Netw. 2021 Jan 6;19(1):48-56. doi: 10.6004/jnccn.2020.7604.

Abstract

BACKGROUND

Gastrostomy tubes (G-tubes) are invaluable clinical tools that play a role in palliation and nutrition in patients with cancer. This study aimed to better understand the risks and benefits associated with the placement and maintenance of G-tubes.

METHODS

Patients who underwent placement of a G-tube for cancer from January 2013 through December 2017 at a tertiary care center were considered for inclusion. Clinical data were retrospectively collected from medical records.

RESULTS

A total of 242 patients with cancer, whose average age at diagnosis was 61 years (range, 21-94 years), underwent G-tube placement for nutrition (76.4%), decompression (22.7%), or both (0.8%). Successful insertion was achieved in 96.8%, but 8 patients required >1 attempted method of insertion. In the decompression group, minor postplacement complications were less common (23.6% vs 53.5%; P<.001) and survival was shorter (P<.001) compared with the nutrition group. For those with decompressive G-tubes, 45.5% had a palliative care consult; 56.4% were seen by social workers; and 46.3% went to hospice. The frequency of hospice discharge was higher in patients who had consults (53.7% vs 23.1%; P=.01).

CONCLUSIONS

Half of the patients who received decompressive G-tubes presented with stage IV disease and died within 1 month of placement. Those with >1 consult were more likely to be discharged to hospice. Patients with G-tubes for nutrition saw no change in functionality, complication rate, or survival, regardless of adjunct chemotherapy status. These findings illustrate the need for a tool to allow a better multidisciplinary approach and interventional decision-making for patients with cancer.

摘要

背景

胃造口管(G 管)是一种非常有价值的临床工具,在癌症患者的姑息治疗和营养支持中发挥着重要作用。本研究旨在更好地了解与 G 管的放置和维护相关的风险和益处。

方法

在一家三级医疗中心,从 2013 年 1 月至 2017 年 12 月期间,对因癌症而接受 G 管放置的患者进行了研究。从病历中回顾性地收集了临床数据。

结果

共有 242 例癌症患者接受了 G 管放置,用于营养支持(76.4%)、减压(22.7%)或两者兼有(0.8%)。有 96.8%的患者成功插入了 G 管,但有 8 名患者需要使用>1 种方法尝试插入。在减压组中,术后并发症较少(23.6% vs. 53.5%;P<.001),生存期较短(P<.001)。对于那些有减压作用的 G 管,有 45.5%的患者接受了姑息治疗咨询;56.4%的患者接受了社会工作者的咨询;46.3%的患者进入了临终关怀。接受咨询的患者中有 53.7%的人被转到了临终关怀,而没有接受咨询的患者只有 23.1%(P=.01)。

结论

一半接受减压 G 管的患者患有 IV 期疾病,并在放置后 1 个月内死亡。接受>1 次咨询的患者更有可能被转到临终关怀。接受营养支持的 G 管患者的功能、并发症发生率或生存率没有变化,无论辅助化疗状况如何。这些发现表明需要一种工具来为癌症患者提供更好的多学科方法和干预决策。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验